Rochester Skin Lymphoma Medical Group is a clinical research site located in Fairport, New York, United States 14450.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Rochester Skin Lymphoma Medical Group has participated in 6 clinical trials.
Therapeutic areas: Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Relapsed/Refractory Peripheral T-cell Lymphoma.
Sponsors: Soligenix, miRagen Therapeutics, Inc., Taiho Oncology, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Fairport
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rochester Skin Lymphoma Medical Group has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rochester Skin Lymphoma Medical Group has 6 clinical trials on record. Their work covers Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Relapsed/Refractory Peripheral T-cell Lymphoma.
Rochester Skin Lymphoma Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.